Journal of the American Chemical Society · 2023 · 13 citations · 41 references
Life SciencesImmunologyPharmaceuticsImmunizationVaccine ImmunologyVaccinologyAdjuvant DesignCancer VaccinesVaccine DeliveryVaccine FormulationVaccine PlatformsViral VaccinesAntigen-adjuvant InteractionsLipid Bilayer MembranesNovel Vaccine Delivery SystemsSelf-assembling Vaccine PlatformsSurface Charge ModificationVaccine Candidate AntigensVaccine Payload EncapsulationViral Capsid Stability
We report a promising cancer vaccine candidate comprising antigen/adjuvant-displaying enveloped viral replica as a novel vaccine platform. The artificial viral capsid, which consists of a self-assembled β-annulus peptide conjugated with an HER2-derived antigenic CH401 peptide, was enveloped within a lipid bilayer containing the lipidic adjuvant α-GalCer. The use of an artificial viral capsid as a scaffold enabled precise control of its size to ∼100 nm, which is generally considered to be optimal for delivery to lymph nodes. The encapsulation of the anionically charged capsid by a cationic lipid bilayer dramatically improved its stability and converted its surface charge to cationic, enhancing its uptake by dendritic cells. The developed CH401/α-GalCer-displaying enveloped viral replica exhibited remarkable antibody-production activity. This study represents a pioneering example of precise vaccine design through bottom-up construction and opens new avenues for the development of effective vaccines.
41
Dennis J. Slamon, Gary M. Clark, Steven Wong et al. · Science · 1987 · 11.7K citations
Generation and Analysis of Interleukin-4 Deficient Mice
Ralf Kühn, Klaus Rajewsky, Werner Müller · Science · 1991 · 1.3K citations
Vani Lakshminarayanan, Pamela Thompson, Margreet A. Wolfert et al. · Proceedings of the National Academy of Sciences · 2011 · 300 citations · Full text
Life Sciences, Immunology, Oncology +17